After applying high-resolution T2-weighted MRI in vivo to both PC3 PIP-inoculated and PC3 flu-inoculated mice, marked contrast enhancement were shown in the PSMA+-tumor-bearing region than the PSMA- one up to 48 hours post-PSMA-targeted BNF NP injection. This evidence concerns the gene FOLH1 and neoplasm.